Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
National Oncology Workshop PET, CT, MRI, Diffusion, Key Medical and Research Aspects for Oncologists Tuesday 3rd November, 2015 08.15am – 16.50pm Venue: Julian Bloom Lecture Theatre, The Education & Conference Centre, The Royal Marsden, Fulham Road, London. SW3 6JJ Agenda 08.15 09.15 09.20 Coffee and registration Chair (AM): Dr Susannah Stanway, Consultant, Medical Oncology, The Royal Marsden NHS Foundation Trust Introduction. Aims. Dr Bhuey Sharma, Consultant Radiologist, The Royal Marsden NHS Foundation Trust CT, PET (SUV max), whole-body DWI in oncology imaging (ADC). What does it all mean? Dr Henry Tam, Consultant Radiologist, Imperial College Healthcare NHS Trust Audience: Medical, clinical and surgical oncology trainees and consultants, oncology fellows, STs in oncology, oncology specialised nurses Aim: To teach clinicians key basic principles of oncological multiparametric imaging in the clinical and research setting (including functional/anatomical PET, WB-DWI, CT, MRI). Clinical and research theme throughout day. 09.55 Dr Bhuey Sharma, Consultant Radiologist, The Royal Marsden NHS Foundation Trust Lung Cancer. TNM; CT, PET, DWI, functional imaging. Radiotherapy. 10.40 Dr Alex Weller, Functional Imaging Fellow, The Royal Marsden NHS Foundation Trust & Institute of Cancer Research 11.15 Tea / Coffee 11.35 GI cancers. CT, MRI, DWI, PET. What is the most accurate method to define liver metastases? Dr Angela Riddell, Consultant Radiologist, The Royal Marsden NHS Foundation Trust 12.10 Breast Cancer. All modalities; we still do not have a single ideal universally available imaging test. ‘Oligometastatic disease’ imaging. Dr Bhuey Sharma, Consultant Radiologist, The Royal Marsden NHS Foundation Trust 12.55 13.55 Organising Committee: Dr Bhuey Sharma Professor Stephen Johnston Dr Susannah Stanway Dr Anastasia Constantinidou Mrs Hannah Holmes Lymphoma. Staging, prognostication, response assessment; the evidence. More questions than answers. 14.10 Complimentary Lunch Chair (PM): Dr Anastasia Constantinidou, Clinical Research Fellow, Institute of Cancer Research & The Royal Marsden NHS Foundation Trust Translational research. Dr Naureen Starling, Consultant Medical Oncologist and Associate Director of Research, Biomedical Research Centre & The Royal Marsden NHS Foundation Trust Pathology. Some key principles for clinicians. Dr Ayoma Attygalle/Dr Andrew Wotherspoon, Consultant Histopathologists, The Royal Marsden NHS Foundation Trust 14.40 Complications. Drug toxicity. Infection patterns. 15.10 Tea / Coffee 15.30 MDM cases. Key generic important learning points across tumour types (including the problem of bone metastases). Dr Axel Martin, Consultant Radiologist, Northwick Park Hospital Dr John Rendle, Consultant Radiologist, Croydon University Hospital 6 CPD points awarded 16.00 Whole Body Diffusion Weighted Imaging (WB-DWI, ADC Maps). When exactly should we be using DWI for cancer patient clinical management today? Do you really want to know ‘the truth’? Likely key translational research in the next couple of years. Dr Nina Tunariu, Consultant Radiologist, The Royal Marsden NHS Foundation Trust 16.45 – 16.50 Summary and close of day. Dr Bhuey Sharma, Consultant Radiologist, The Royal Marsden NHS Foundation Trust